Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...
In a breakthrough for people with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication, which will be marketed under the name ...
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...
She asked us to use only her first name because of the stigma associated with schizophrenia. When she was first put on an antipsychotic drug, she says it made her feel like a zombie. Watching a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback